Last updated on August 2016

Effect of Hepatic and Renal Impairment on the Pharmacokinetics Safety and Tolerability of BAY1841788 (ODM-201)

Brief description of study

Evaluate the potential effect of hepatic or renal impairment on the pharmacokinetics, safety and tolerability of BAY 1841788 (ODM-201).

Clinical Study Identifier: NCT02894385

Find a site near you

Start Over